CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20 enrolled
Drug / intervention
Duloxetinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00464698
NCT00464698Phase 4Completed
CompareCT.gov

Duloxetine for the Treatment of Obsessive Compulsive Disorder

Massachusetts General Hospital·interventional·Posted Apr 24, 2007·Updated Mar 19, 2019

In Brief

A Phase 4 clinical trial evaluating Duloxetine for Obsessive Compulsive Disorder. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the efficacy of Duloxetine in the treatment of obsessive compulsive disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObsessive Compulsive Disorder
CountriesUnited States
CollaboratorsEli Lilly and Company

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 24, 2007
Enrollment StartDec 1, 2005
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8 yearsPosted 19.2 years ago

Interventions

Duloxetinedrug

Participants received increasing amounts of Duloxetine for 7 weeks.